WellTheory Raises $14M to Build the Category Leader in Autoimmune Care

Financing Gas AI-Enabled Customization, Industrial Growth, and Collaborations With Leading Companies and Payors

WellTheory, the leading whole-person treatment system for autoimmune condition, today revealed it has actually increased $14 million in Collection A financing led by General Catalyst with engagement from brand-new and present financiers, consisting of 7wire Ventures, Ingeborg Investments, Accel, Box Team, Leaps by Bayer, and Up2 Possibility Fund. With $26.2 million in complete resources, this brand-new financing will certainly sustain WellTheory’s business development, speed up AI advancement, and increase programs that satisfy expanding need from companies and payors.

Autoimmune condition is among the fastest-growing and most pricey groups in health care, folding the last 3 years and influencing greater than 50 million Americans coping with problems such as rheumatoid joint inflammation, lupus, and numerous sclerosis. The autoimmune classification currently stands for a growing market valued at over 160 billion dollars, and has actually come to be a leading invest classification for companies and payors. With specialized medicine expenses climbing up, payors and companies are quickly looking for remedies that both boost client results and minimize invest.

” WellTheory is developing the future of autoimmune treatment with a version that’s distinctively developed for today’s labor force,” stated Ellen Rudolph, Founder and Chief Executive Officer at WellTheory. “Companies are dealing with increasing expenses, while workers wait years for solutions by themselves health and wellness– a discouraging trip I experienced firsthand. By incorporating high-touch treatment with AI-enabled customization, we’re attending to both celebrations, supplying a much better lifestyle for individuals and quantifiable expense decreases for companies and payors.”

” WellTheory is attending to the influence of autoimmune condition by identifying the crucial duty that diet plan and way of life can play in sustaining individuals,” stated Candace Richardson, Companion at General Stimulant, that is signing up with the firm’s board. “The system is showing exactly how this type of assistance can be provided at range, and this is simply the start. It is broadening to incorporate clinical therapy and medicine monitoring, producing an extra extensive design developed to boost client experiences and enhance system sustainability.”

WellTheory will certainly make use of the financing to grow collaborations with companies and payors, increase treatment programs targeting the fastest-growing expense facilities in health care, and purchase AI-enabled customization. With each other, these initiatives will certainly permit the firm to provide whole-person autoimmune treatment at a higher range while minimizing expenses for individuals and companions alike.

” Companies and payers are quickly looking for remedies that boost results while minimizing expenses. WellTheory’s AI-powered, whole-person design is confirming it can do both,” stated Tiffany Yu, Principal at 7wire Ventures. “We are excited by the firm’s capability to provide significant financial savings for its companions today while likewise establishing a brand-new requirement for a customized, consumer-first experience.”

In simply 18 months on the business market, WellTheory has actually safeguarded collaborations with Lot of money 100 and 500 companies and high-growth business, consisting of Expert Facility, Ton Of Money Brands Innovations, and Dayforce, in addition to payors such as Sentara Health and wellness Program and among the leading nationwide payors. These companions are currently seeing quantifiable influence: independent cases evaluations reveal WellTheory lowers emergency room check outs, imaging, hospital stays, and biologics usage while conserving hundreds of bucks per client each year.

In the previous year alone, WellTheory has actually seen 10 × year-over-year participant development and 5 × profits development– highlighting both the range of the requirement and the efficiency of its design. This energy improves the firm’s current launch of its AI-powered system, which presented exclusive devices Treatment Center and Treatment Scribe, currently completely released throughout its treatment procedures.

Regarding WellTheory

WellTheory is an online treatment system turning around the autoimmune epidemic by filling up the spaces left in standard health care. WellTheory supplies a research-backed exclusive program that resolves the source of autoimmunity and deals with the entire individual with the goal to minimize signs, boost lifestyle, and reduced expenses. WellTheory’s system facilities around evidence-based, high-touch treatment led by an interdisciplinary group of autoimmune specialists, consisting of qualified signed up dietitians and board-certified health and wellness instructors. It’s an anti-symptom-masking design that exceeds the tablet, developed by autoimmune individuals and verified by years of scientific research study.

Regarding General Stimulant

General Stimulant is an international financial investment and makeover firm that companions with the globe’s most enthusiastic business owners to drive durability and used AI. We sustain owners with a long-lasting sight that rock the boat, partnering with them from seed to development phase and past. With workplaces in San Francisco, New York City City, Boston, Berlin, Bangalore, and London, we have actually sustained the development of 800+ companies, consisting of Airbnb, Anduril, Applied Instinct, Commure, Glean, Guild, Gusto, Helsing, Hubspot, Kayak, Livongo, Mistral, Ramp, Samsara, Break, Red Stripe, Sword, and Zepto.

For more details, look into generalcatalyst.com or follow us on Twitter @generalcatalyst.

Initially revealed October 14th, 2025